•                                                                                                                                                                                                                                                                                                                                                                                           English
  • ——
    副高
    您现在的位置:首页 >> 医院信息 >> 副高

    彭芳

    医疗特长介绍
    医疗特长:擅长胸腹部肿瘤(包括肺癌、食管癌、胸腺肿瘤等)的诊断和放射治疗为主的肿瘤综合治疗。

    其他情况介绍
    研究方向:胸腹部肿瘤(包括肺癌、食管癌、胸腺肿瘤等)的放射治疗为主的肿瘤综合治疗。

    主要教育和工作经历:
    教育经历:
    2012/08-2013/05,美国密歇根大学,放疗科,访问学者
    2008/09-2013/06,中山大学肿瘤防治中心 ,博士
    2003/09-2008/07,中山大学,临床医学系,学士
    工作经历:
    2019/12-至今,中山大学附属第一医院,副主任医师
    2017/01-2019/12,中山大学附属第一医院,主治医师
    2013/07-2016/12,中山大学附属第一医院 ,医师
    社会兼职:
    广东省医院协会放疗科管理专委会青年委员
    1. 论著:Honglian M#,Zhouguang H#,Fang, P#, et al. Different administration routes of recombinant human endostatin combined with concurrent chemoradiotherapy might lead to different efficacy and safety profile  in unresectable stage III non-small cell lung cancer: Updated follow-up results from two phase II trials. Thorac Cancer, 2020,11(4):898-906.
    2. Fang Peng#, Bao Yong, Chen, Likun, et al. Increased Radiation Pneumonitis after Crizotinib and Concurrent Thoracic Radiotherapy in Patients with ALK-positive Non-small-cell Lung Cancer,Int J Radiat Oncol Biol Phys, 2019. 105S(1): p. S148-S149.
    3. Fang Peng#,Qiang Li#,Shao?Qing Niu#, et al. ZWINT is the next potential target for lung cancer therapy. J Cancer Res Clin Oncol, 2019. 145(3): p. 661-673.
    4. Fang Peng #, Qiang Li #,Jia-Yuan Sun #, et al.PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis. International journal of oncology, 2018. 52(3): p. 945-954.
    5. He Zhen-Yu#,Wu San-Gang#,Peng Fang#, et al.Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT,

    Translational oncology, 2017, 10(1), 1-9.
    6. Yong Bao#, Fang Peng #, Qi-Chao Zhou#, et al. Phase II trial of recombinant human endostatin in combination with concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer. Radiotherapy and Oncology, 2015, 114(2),161-166
    7. Z Xu#, Y Dong#, F Peng#, et al.Pigment epithelium-derived factor enhances tumor response to radiation through vasculature normalization in allografted lung cancer in mice. Cancer Gene Therapy , 2015, 22(4), 181-187
    8. San-Gang Wu#, Fang Peng#, Juan Zhou#, et al. Number of Negative Lymph Nodes Can Predict Survival after Postmastectomy Radiotherapy According to Different Breast Cancer Subtypes. Journal of Cancer, 2015; 6(3): 261-269
    9. Fang Peng#, Zumin Xu#, Jin Wang#, et al. Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models. PLoS One, 2012. 7(4): p. e34646
    10. 彭芳#、陈明*, 放疗联合分子靶向药物治疗非小细胞肺癌的研究进展. 实用肿瘤学杂志, 2012. 26(01): 42-48
    11. 彭芳#、王谨、邹毅等,重组内皮抑素对肿瘤血管结构和乏氧改善作用的实验观察. 中华放射肿瘤学杂志, 2011. 20(1): 69-72
    12. Fang Peng #, Ming Chen*, Antiangiogenic therapy: a novel approach to overcome tumor hypoxia. Chin J Cancer, 2010,29(8): 715-20
    13. 彭芳#、陈明*, 抗血管生成和肿瘤血管正常化的研究进展. 中国肺癌杂志, 2009(7): 799-804

    专著:无

    其他主要工作成绩(比如获奖情况):
    肺癌精准放疗关键技术的研发、应用和推广,浙江省医药卫生科技奖,一等奖,2016 (第六完成人)。